Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021


HomeEXECUTIVESThomas Berryman New Chief Financial Officer at Q'Apel Medical

Thomas Berryman New Chief Financial Officer at Q’Apel Medical

Thomas Berryman welcomed by the Q’Apel Medical team

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Thomas Berryman as Chief Financial Officer.

Thomas Berryman has extensive experience in bringing venture-funded medical technology companies from initial startup through product commercialization, revenue growth and exit.

Thomas Berryman is the founder of Privy, the maker of Finess®, a novel FDA-cleared and clinically validated technology for a large consumer health market. Prior to founding Privy, he served as President and CEO of WaveTec Vision Systems (now part of Alcon) from its initial venture funding in 2005, taking it from benchtop prototype through clinical validation and early commercialization, until September 2010. Prior to joining WaveTec, Tom was Founder/CEO of Genyx Medical, Inc., which he sold to C.R. Bard in 2005. Prior to founding Genyx, he was with Micro Therapeutics, Inc. (now Medtronic Neurovascular) from 1994 through 1997 as its CFO.

“We are thrilled to have Tom join the Q’Apel Medical Team. Tom brings an extensive amount of experience not only with start-up companies but has played a key role in growth companies through exit. We are very lucky to have Tom on our team,” said King Nelson, CEO of Q’Apel Medical. “Tom complements our strong performance-oriented culture, and we believe his experience and results-oriented track record is critical to lead Q’Apel into the next stage of growth.”

“I’m honored to join the Q’Apel team and delighted to once again to participate in the neurovascular space. It is truly gratifying to participate in bringing innovative, life-saving technologies to physicians and their patients,” said Thomas Berryman.

Q’Apel Medical plans to acquire CE Certification and expand into Europe later this year. Q’Apel Medical products are currently being utilized in over 190 hospital systems nationwide.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy